Enhanced Cancer Immunotherapy By Microneedle Patch- Assisteddelivery of Anti-PD1 Antibody

摘要

For skin cancer treatment, immunotherapies have been intensively studied over the past several years). The anti-PD-1 antibodies that target the inhibitory receptors have shown striking antitumor activity in phase II and III clinical trials of advanced melanoma). Despite the exciting clinical results of anti-PD-1 antibodies for the treatment of melanoma, the e cacy of the approach remains to be improved.